Tick-Borne Encephalitis Vaccine Effectiveness and Impact in Slovenia, 2019-2024.

Saved in:
Bibliographic Details
Title: Tick-Borne Encephalitis Vaccine Effectiveness and Impact in Slovenia, 2019-2024.
Authors: Kordež J; Medical and Scientific Affairs, Pfizer, SI-1000 Ljubljana, Slovenia., Angulo FJ; Medical Evidence Development, Bacterial Vaccines Real-World Evidence and Epidemiology, Pfizer, Collegeville, PA 19426, USA., Zhang P; Medical Affairs Evidence Generation Statistics, Pfizer Research and Development, Collegeville, PA 19426, USA., Davidson A; Medical Evidence Development, Bacterial Vaccines Real-World Evidence and Epidemiology, Pfizer, New York, NY 19426, USA., Edwards J; Medical Evidence Generation, Bacterial Vaccines Real-World Evidence and Epidemiology, Pfizer, Collegeville, PA 19426, USA., Harper LR; Medical Evidence Development, Vaccines, Integrated Evidence Generation, Pfizer, Collegeville, PA 19426, USA., Pilz A; Global Medical Affairs, Bacterial and Vector-Borne Vaccines, Pfizer Biopharma, 1210 Vienna, Austria., Gould H; Global Medical Affairs, Bacterial and Vector-Borne Vaccines, Pfizer Research and Development, New York, NY 10001, USA.
Source: Pathogens (Basel, Switzerland) [Pathogens] 2026 May 07; Vol. 15 (5). Date of Electronic Publication: 2026 May 07.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101596317 Publication Model: Electronic Cited Medium: Internet ISSN: 2076-0817 (Electronic) Linking ISSN: 20760817 NLM ISO Abbreviation: Pathogens Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2076-0817
DOI:10.3390/pathogens15050503